Request Appointment
3959 BroadwayNew York, NY 10032
Fax+1 212-342-2293
Overview of Dr. Geneslaw
Dr. Andrew Geneslaw is a pediatrician in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Tufts University School of Medicine and has been in practice 5 years. He is one of 728 doctors at New York-Presbyterian Hospital and one of 254 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pediatrics. He has more than 20 publications and over 350 citings.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Critical Care Medicine, 2016 - 2019- New York Presbyterian Hospital (Columbia Campus)Chief Residency, Pediatrics, 2015 - 2016
- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2012 - 2015
Tufts University School of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2014 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Critical Care Medicine
Publications & Presentations
PubMed
- Pulse rate variability as a predictor for length of stay for patients with bronchiolitis in the pediatric intensive care unit.Soon Bin Kwon, Bennett Weinerman, Daniel Nametz, Tammam Alalqum, Isaac S Lee
Journal of Clinical Monitoring and Computing. 2025-06-01 - Neurodevelopmental and behavioural disorders after perioperative invasive mechanical ventilation in paediatric surgical admissions.Oliver G Isik, Ling Guo, Ariel Ben-Ezra, Sandya Ganesh, May Hua
British Journal of Anaesthesia. 2025-05-01 - Reducing Chest Compression Pauses During Pediatric ECPR.Elena M Insley, Andrew S Geneslaw, Tarif A Choudhury, Anita I Sen
Journal of Intensive Care Medicine. 2025-05-01
Press Mentions
Columbia Pediatrics Researchers Receive Seed Funding for Innovative ResearchFebruary 20th, 2020
Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and RationaleMay 29th, 2020
A Step in De-MIS-Tifying MIS-C: The Importance of Early Immunomodulatory Therapy in MIS-CAugust 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
